James BakerDr James Baker is Head of DMPK at Blueprint Medicines, with over twenty-five years in drug discovery at Merck, Pfizer, Organon, and Schering-Plough. He is a past Chair of the New England Drug Metabolism Discussion Group and serves on the IQ Consortiu's Translational ADME Leadership Group. Read More Read Less
An OTP has been sent to your Registered Email Id:
Resend Verification Code
Hi! I'm Vidya, your virtual assistant.
Need a book recommendation, help with your order or support with any query? I’m here to assist you.